Product Code:46953
Published Date: Jun 05,2021
Pages: 95
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
According to this latest study, the 2021 growth of Polio Vaccine will have significant change from previous year. By the most conservative estimates of global Polio Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 655 million in 2020. Over the next five years the Polio Vaccine market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 775.5 million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Polio Vaccine market by product type, application, key manufacturers and key regions and countries. Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7. Inactivated Polio Vaccine (IPV) Oral Polio Vaccine (OPV) Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8. Public Private This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3. Sanofi GSK Bibcol Serum Institute Tiantan Biological IMBCA Panacea Biotec Ltd Bio-Med Halfkin Bio-Pharmaceuticals
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Polio Vaccine Consumption 2016-2026
2.1.2 Polio Vaccine Consumption CAGR by Region
2.2 Polio Vaccine Segment by Type
2.2.1 Inactivated Polio Vaccine (IPV)
2.2.2 Oral Polio Vaccine (OPV)
2.3 Polio Vaccine Sales by Type
2.3.1 Global Polio Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Polio Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Polio Vaccine Sale Price by Type (2016-2021)
2.4 Polio Vaccine Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Polio Vaccine Sales by Application
2.5.1 Global Polio Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Polio Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Polio Vaccine Sale Price by Application (2016-2021)
3 Global Polio Vaccine by Company
3.1 Global Polio Vaccine Sales Market Share by Company
3.1.1 Global Polio Vaccine Sales by Company (2019-2021)
3.1.2 Global Polio Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Polio Vaccine Revenue Market Share by Company
3.2.1 Global Polio Vaccine Revenue by Company (2019-2021)
3.2.2 Global Polio Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Polio Vaccine Sale Price by Company
3.4 Global Manufacturers Polio Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Polio Vaccine Product Location Distribution
3.4.2 Players Polio Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Polio Vaccine by Region
4.1 Global Polio Vaccine by Region
4.1.1 Global Polio Vaccine Sales by Region
4.1.2 Global Polio Vaccine Revenue by Region
4.2 Americas Polio Vaccine Sales Growth
4.3 APAC Polio Vaccine Sales Growth
4.4 Europe Polio Vaccine Sales Growth
4.5 Middle East & Africa Polio Vaccine Sales Growth
5 Americas
5.1 Americas Polio Vaccine Sales by Country
5.1.1 Americas Polio Vaccine Sales by Country (2016-2021)
5.1.2 Americas Polio Vaccine Revenue by Country (2016-2021)
5.2 Americas Polio Vaccine Sales by Type
5.3 Americas Polio Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Polio Vaccine Sales by Region
6.1.1 APAC Polio Vaccine Sales by Region (2016-2021)
6.1.2 APAC Polio Vaccine Revenue by Region (2016-2021)
6.2 APAC Polio Vaccine Sales by Type
6.3 APAC Polio Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Polio Vaccine by Country
7.1.1 Europe Polio Vaccine Sales by Country (2016-2021)
7.1.2 Europe Polio Vaccine Revenue by Country (2016-2021)
7.2 Europe Polio Vaccine Sales by Type
7.3 Europe Polio Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Polio Vaccine by Country
8.1.1 Middle East & Africa Polio Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Polio Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Polio Vaccine Sales by Type
8.3 Middle East & Africa Polio Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Polio Vaccine Distributors
10.3 Polio Vaccine Customer
11 Global Polio Vaccine Market Forecast
11.1 Global Polio Vaccine Forecast by Region
11.1.1 Global Polio Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Polio Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Polio Vaccine Forecast by Type
11.7 Global Polio Vaccine Forecast by Application
12 Key Players Analysis
12.1 Sanofi
12.1.1 Sanofi Company Information
12.1.2 Sanofi Polio Vaccine Product Offered
12.1.3 Sanofi Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Sanofi Main Business Overview
12.1.5 Sanofi Latest Developments
12.2 GSK
12.2.1 GSK Company Information
12.2.2 GSK Polio Vaccine Product Offered
12.2.3 GSK Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 GSK Main Business Overview
12.2.5 GSK Latest Developments
12.3 Bibcol
12.3.1 Bibcol Company Information
12.3.2 Bibcol Polio Vaccine Product Offered
12.3.3 Bibcol Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Bibcol Main Business Overview
12.3.5 Bibcol Latest Developments
12.4 Serum Institute
12.4.1 Serum Institute Company Information
12.4.2 Serum Institute Polio Vaccine Product Offered
12.4.3 Serum Institute Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Serum Institute Main Business Overview
12.4.5 Serum Institute Latest Developments
12.5 Tiantan Biological
12.5.1 Tiantan Biological Company Information
12.5.2 Tiantan Biological Polio Vaccine Product Offered
12.5.3 Tiantan Biological Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Tiantan Biological Main Business Overview
12.5.5 Tiantan Biological Latest Developments
12.6 IMBCA
12.6.1 IMBCA Company Information
12.6.2 IMBCA Polio Vaccine Product Offered
12.6.3 IMBCA Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 IMBCA Main Business Overview
12.6.5 IMBCA Latest Developments
12.7 Panacea Biotec Ltd
12.7.1 Panacea Biotec Ltd Company Information
12.7.2 Panacea Biotec Ltd Polio Vaccine Product Offered
12.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Panacea Biotec Ltd Main Business Overview
12.7.5 Panacea Biotec Ltd Latest Developments
12.8 Bio-Med
12.8.1 Bio-Med Company Information
12.8.2 Bio-Med Polio Vaccine Product Offered
12.8.3 Bio-Med Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Bio-Med Main Business Overview
12.8.5 Bio-Med Latest Developments
12.9 Halfkin Bio-Pharmaceuticals
12.9.1 Halfkin Bio-Pharmaceuticals Company Information
12.9.2 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Offered
12.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Halfkin Bio-Pharmaceuticals Main Business Overview
12.9.5 Halfkin Bio-Pharmaceuticals Latest Developments
13 Research Findings and Conclusion
List of Tables Table 1. Polio Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Inactivated Polio Vaccine (IPV) Table 3. Major Players of Oral Polio Vaccine (OPV) Table 4. Global Polio Vaccine Sales by Type (2016-2021) & (M Doses) Table 5. Global Polio Vaccine Sales Market Share by Type (2016-2021) Table 6. Global Polio Vaccine Revenue by Type (2016-2021) & ($ million) Table 7. Global Polio Vaccine Revenue Market Share by Type (2016-2021) Table 8. Global Polio Vaccine Sale Price by Type (2016-2021) Table 9. Global Polio Vaccine Sales by Application (2016-2021) & (M Doses) Table 10. Global Polio Vaccine Sales Market Share by Application (2016-2021) Table 11. Global Polio Vaccine Value by Application (2016-2021) Table 12. Global Polio Vaccine Revenue Market Share by Application (2016-2021) Table 13. Global Polio Vaccine Sale Price by Application (2016-2021) Table 14. Global Polio Vaccine Sales by Company (2019-2021) & (M Doses) Table 15. Global Polio Vaccine Sales Market Share by Company (2019-2021) Table 16. Global Polio Vaccine Revenue by Company (2019-2021) ($ Millions) Table 17. Global Polio Vaccine Revenue Market Share by Company (2019-2021) Table 18. Global Polio Vaccine Sale Price by Company (2019-2021) Table 19. Key Manufacturers Polio Vaccine Producing Area Distribution and Sales Area Table 20. Players Polio Vaccine Products Offered Table 21. Polio Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Polio Vaccine Sales by Region (2016-2021) (M Doses) Table 25. Global Polio Vaccine Sales Market Share by Region (2016-2021) Table 26. Global Polio Vaccine Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Polio Vaccine Revenue Market Share by Region (2016-2021) Table 28. Americas Polio Vaccine Sales by Country (2016-2021) & (M Doses) Table 29. Americas Polio Vaccine Sales Market Share by Country (2016-2021) Table 30. Americas Polio Vaccine Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Polio Vaccine Revenue Market Share by Country (2016-2021) Table 32. Americas Polio Vaccine Sales by Type (2016-2021) & (M Doses) Table 33. Americas Polio Vaccine Sales Market Share by Type (2016-2021) Table 34. Americas Polio Vaccine Sales by Application (2016-2021) & (M Doses) Table 35. Americas Polio Vaccine Sales Market Share by Application (2016-2021) Table 36. APAC Polio Vaccine Sales by Region (2016-2021) & (M Doses) Table 37. APAC Polio Vaccine Sales Market Share by Region (2016-2021) Table 38. APAC Polio Vaccine Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Polio Vaccine Revenue Market Share by Region (2016-2021) Table 40. APAC Polio Vaccine Sales by Type (2016-2021) & (M Doses) Table 41. APAC Polio Vaccine Sales Market Share by Type (2016-2021) Table 42. APAC Polio Vaccine Sales by Application (2016-2021) & (M Doses) Table 43. APAC Polio Vaccine Sales Market Share by Application (2016-2021) Table 44. Europe Polio Vaccine Sales by Country (2016-2021) & (M Doses) Table 45. Europe Polio Vaccine Sales Market Share by Country (2016-2021) Table 46. Europe Polio Vaccine Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Polio Vaccine Revenue Market Share by Country (2016-2021) Table 48. Europe Polio Vaccine Sales by Type (2016-2021) & (M Doses) Table 49. Europe Polio Vaccine Sales Market Share by Type (2016-2021) Table 50. Europe Polio Vaccine Sales by Application (2016-2021) & (M Doses) Table 51. Europe Polio Vaccine Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Polio Vaccine Sales by Country (2016-2021) & (M Doses) Table 53. Middle East & Africa Polio Vaccine Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Polio Vaccine Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Polio Vaccine Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Polio Vaccine Sales by Type (2016-2021) & (M Doses) Table 57. Middle East & Africa Polio Vaccine Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Polio Vaccine Sales by Application (2016-2021) & (M Doses) Table 59. Middle East & Africa Polio Vaccine Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Polio Vaccine Table 61. Key Application and Potential Industries of Polio Vaccine Table 62. Key Challenges of Polio Vaccine Table 63. Key Trends of Polio Vaccine Table 64. Polio Vaccine Distributors List Table 65. Polio Vaccine Customer List Table 66. Global Polio Vaccine Sales Forecast by Region (2021-2026) & (M Doses) Table 67. Global Polio Vaccine Consumption Market Forecast by Region Table 68. Global Polio Vaccine Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Polio Vaccine Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Polio Vaccine Sales Forecast by Country (2021-2026) & (M Doses) Table 71. Americas Polio Vaccine Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Polio Vaccine Sales Forecast by Region (2021-2026) & (M Doses) Table 73. APAC Polio Vaccine Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Polio Vaccine Sales Forecast by Country (2021-2026) & (M Doses) Table 75. Europe Polio Vaccine Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Polio Vaccine Sales Forecast by Country (2021-2026) & (M Doses) Table 77. Middle East & Africa Polio Vaccine Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Polio Vaccine Sales Forecast by Type (2021-2026) & (M Doses) Table 79. Global Polio Vaccine Sales Market Share Forecast by Type (2021-2026) Table 80. Global Polio Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Polio Vaccine Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Polio Vaccine Sales Forecast by Application (2021-2026) & (M Doses) Table 83. Global Polio Vaccine Sales Market Share Forecast by Application (2021-2026) Table 84. Global Polio Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Polio Vaccine Revenue Market Share Forecast by Application (2021-2026) Table 86. Sanofi Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 87. Sanofi Polio Vaccine Product Offered Table 88. Sanofi Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E) Table 89. Sanofi Main Business Table 90. Sanofi Latest Developments Table 91. GSK Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 92. GSK Polio Vaccine Product Offered Table 93. GSK Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E) Table 94. GSK Main Business Table 95. GSK Latest Developments Table 96. Bibcol Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 97. Bibcol Polio Vaccine Product Offered Table 98. Bibcol Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E) Table 99. Bibcol Main Business Table 100. Bibcol Latest Developments Table 101. Serum Institute Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 102. Serum Institute Polio Vaccine Product Offered Table 103. Serum Institute Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E) Table 104. Serum Institute Main Business Table 105. Serum Institute Latest Developments Table 106. Tiantan Biological Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 107. Tiantan Biological Polio Vaccine Product Offered Table 108. Tiantan Biological Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E) Table 109. Tiantan Biological Main Business Table 110. Tiantan Biological Latest Developments Table 111. IMBCA Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 112. IMBCA Polio Vaccine Product Offered Table 113. IMBCA Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E) Table 114. IMBCA Main Business Table 115. IMBCA Latest Developments Table 116. Panacea Biotec Ltd Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 117. Panacea Biotec Ltd Polio Vaccine Product Offered Table 118. Panacea Biotec Ltd Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E) Table 119. Panacea Biotec Ltd Main Business Table 120. Panacea Biotec Ltd Latest Developments Table 121. Bio-Med Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 122. Bio-Med Polio Vaccine Product Offered Table 123. Bio-Med Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E) Table 124. Bio-Med Main Business Table 125. Bio-Med Latest Developments Table 126. Halfkin Bio-Pharmaceuticals Basic Information, Polio Vaccine Manufacturing Base, Sales Area and Its Competitors Table 127. Halfkin Bio-Pharmaceuticals Polio Vaccine Product Offered Table 128. Halfkin Bio-Pharmaceuticals Polio Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2019-2021E) Table 129. Halfkin Bio-Pharmaceuticals Main Business Table 130. Halfkin Bio-Pharmaceuticals Latest Developments List of Figures Figure 1. Picture of Polio Vaccine Figure 2. Polio Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Polio Vaccine Sales Growth Rate 2016-2026 (M Doses) Figure 7. Global Polio Vaccine Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Polio Vaccine Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Inactivated Polio Vaccine (IPV) Figure 10. Product Picture of Oral Polio Vaccine (OPV) Figure 11. Global Polio Vaccine Sales Market Share by Type in 2020 Figure 12. Global Polio Vaccine Revenue Market Share by Type (2016-2021) Figure 13. Polio Vaccine Consumed in Public Figure 14. Global Polio Vaccine Market: Public (2016-2021) & (M Doses) Figure 15. Polio Vaccine Consumed in Private Figure 16. Global Polio Vaccine Market: Private (2016-2021) & (M Doses) Figure 17. Global Polio Vaccine Sales Market Share by Application (2016-2021) Figure 18. Global Polio Vaccine Revenue Market Share by Application in 2020 Figure 19. Polio Vaccine Revenue Market by Company in 2020 ($ Million) Figure 20. Global Polio Vaccine Revenue Market Share by Company in 2020 Figure 21. Global Polio Vaccine Sales Market Share by Regions (2016-2021) Figure 22. Global Polio Vaccine Revenue Market Share by Region in 2020 Figure 23. Americas Polio Vaccine Sales 2016-2021 (M Doses) Figure 24. Americas Polio Vaccine Revenue 2016-2021 ($ Millions) Figure 25. APAC Polio Vaccine Sales 2016-2021 (M Doses) Figure 26. APAC Polio Vaccine Revenue 2016-2021 ($ Millions) Figure 27. Europe Polio Vaccine Sales 2016-2021 (M Doses) Figure 28. Europe Polio Vaccine Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Polio Vaccine Sales 2016-2021 (M Doses) Figure 30. Middle East & Africa Polio Vaccine Revenue 2016-2021 ($ Millions) Figure 31. Americas Polio Vaccine Sales Market Share by Country in 2020 Figure 32. Americas Polio Vaccine Revenue Market Share by Country in 2020 Figure 33. Americas Polio Vaccine Sales Market Share by Type in 2020 Figure 34. Americas Polio Vaccine Sales Market Share by Application in 2020 Figure 35. United States Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Polio Vaccine Sales Market Share by Region in 2020 Figure 40. APAC Polio Vaccine Revenue Market Share by Regions in 2020 Figure 41. APAC Polio Vaccine Sales Market Share by Type in 2020 Figure 42. APAC Polio Vaccine Sales Market Share by Application in 2020 Figure 43. China Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 47. India Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Polio Vaccine Sales Market Share by Country in 2020 Figure 50. Europe Polio Vaccine Revenue Market Share by Country in 2020 Figure 51. Europe Polio Vaccine Sales Market Share by Type in 2020 Figure 52. Europe Polio Vaccine Sales Market Share by Application in 2020 Figure 53. Germany Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 54. France Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Polio Vaccine Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Polio Vaccine Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Polio Vaccine Sales Market Share by Type in 2020 Figure 61. Middle East & Africa Polio Vaccine Sales Market Share by Application in 2020 Figure 62. Egypt Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Polio Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles
Sanofi GSK Bibcol Serum Institute Tiantan Biological IMBCA Panacea Biotec Ltd Bio-Med Halfkin Bio-Pharmaceuticals
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape
RELATED REPORTS
Jan
2024
Global Polio Vaccine Market Growth 2024-2030
Pages: 94|Category: PHARMA & HEALTHCARE
According to our LPI (LP Information) latest study, the global Polio Vaccine market size was valued at US$ 694.4 million in 2023. With growing demand in downstream market, the Polio Vaccine is forecast to a readjusted size of US$ 935.9 million by 2030 with a CAGR of 4.4% during review period.
$3660.00
Aug
2020
Global Polio Vaccine Market Growth 2020-2025
Pages: 135|Category: PHARMA & HEALTHCARE
According to this study, over the next five years the Polio Vaccine market will register a 5.5%% CAGR in terms of revenue, the global market size will reach $ 1638.1 million by 2025, from $ 1322.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Polio Vaccine business, shared in Chapter 3.
$3660.00